Discarded leukoreduction filters: A new source of stem cells for research, cell engineering and therapy?

Stem Cell Research

Volumn 11, Issue 2, 2013, Pages 736-742

  Peytour, Yann ^a,b   Villacreces, Arnaud ^a   Chevaleyre, Jean ^a,b   Ivanovic, Zoran ^a,b   Praloran, Vincent ^a,c  

^a CNRS Bordeaux Segalen University   (France)

^b ETABLISSEMENT FRANÇAIS DU SANG   (France)

^c BORDEAUX UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN;

BONE MARROW; BONE MARROW TRANSPLANTATION; CELL ENGINEERING; CORD BLOOD STEM CELL TRANSPLANTATION; ELUTION; ERYTHROCYTE CONCENTRATE; FILTER; HEMATOLOGICAL PARAMETERS; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; LEUKOREDUCTION FILTER; MEDICAL RESEARCH; PRIORITY JOURNAL; REVIEW; STEADY STATE PERIPHERAL BLOOD; STEM CELL ENGINEERING;

BM; BONE MARROW; CB; G-CSF; GRANULOCYTE COLONY STIMULATING FACTOR; HEMATOPOIETIC PROGENITORS; HEMATOPOIETIC STEM CELLS; HPS; HSCS; INDUCED PLURIPOTENT STEM CELLS; IPS CELLS; LEUKOREDUCTION FILTERS; LRFS; PB; PERIPHERAL BLOOD; RBCS; RED BLOOD CELLS; SSPB; STEADY STATE PERIPHERAL BLOOD; UMBILICAL CORD BLOOD; WBCS; WHITE BLOOD CELLS.;

ANIMALS; BLOOD PRESERVATION; CELL ENGINEERING; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELLS; HUMANS; LEUKOCYTE REDUCTION PROCEDURES; STEM CELL RESEARCH;

EID: 84878785140     PISSN: 18735061     EISSN: 18767753     Source Type: Journal    
DOI: 10.1016/j.scr.2013.05.001     Document Type: Review

References (50)

1. Barker J.N., Weisdorf D.J., DeFor T.E., Blazar B.R., McGlave P.B., Miller J.S., Verfaillie C.M., Wagner J.E. Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy. Blood 2005, 105(3):1343-1347.
2. Benboubker L., Watier H., Carion A., Georget M.T., Desbois I., Colombat P., Bardos P., Binet C., Domenech J. Association between the SDF1-3'A allele and high levels of CD34(+) progenitor cells mobilized into peripheral blood in humans. Br. J. Haematol. 2001, 113(1):247-250.
3. Bender J.G., Unverzagt K.L., Walker D.E., Lee W., Van Epps D.E., Smith D.H., Stewart C.C., To L.B. Identification and comparison of CD34-positive cells and their subpopulations from normal peripheral blood and bone marrow using multicolor flow cytometry. Blood 1991, 77(12):2591-2596.
4. Bosi A., Bartolozzi B. Safety of bone marrow stem cell donation: a review. Transplant. Proc. 2010, 42(6):2192-2194.
5. Bradford G.B., Williams B., Rossi R., Bertoncello I. Quiescence, cycling, and turnover in the primitive hematopoietic stem cell compartment. Exp. Hematol. 1997, 25(5):445-453.
6. Brecher G., Cronkite E.P. Post-radiation parabiosis and survival in rats. Proc. Soc. Exp. Biol. Med. 1951, 77(2):292-294.
7. Brunstein C.G., Laughlin M.J. Extending cord blood transplant to adults: dealing with problems and results overall. Semin. Hematol. 2010, 47(1):86-96.
8. Brunet de la Grange P., Vlaski M., Duchez P., Chevaleyre J., Lapostolle V., Boiron J.M., Praloran V., Ivanovic Z. Long-term repopulating hematopoietic stem cells and "side population" in human steady state peripheral blood. Stem Cell Res. 2013, 11(1):625-633.
9. Brunstein C.G., Barker J.N., Weisdorf D.J., DeFor T.E., Miller J.S., Blazar B.R., McGlave P.B., Wagner J.E. Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplantation outcomes in 110 adults with hematologic disease. Blood 2007, 110(8):3064-3070.
10. Chou B.K., Mali P., Huang X., Ye Z., Dowey S.N., Resar L.M., Zou C., Zhang Y.A., Tong J., Cheng L. Efficient human iPS cell derivation by a non-integrating plasmid from blood cells with unique epigenetic and gene expression signatures. Cell Res. 2011, 21(3):518-529.
11. Civin C.I., Strauss L.C., Brovall C., Fackler M.J., Schwartz J.F., Shaper J.H. Antigenic analysis of hematopoiesis. III. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-1a cells. J. Immunol. 1984, 133(1):157-165.
12. Deeg H.J., Bartenstein M. Allogeneic hematopoietic cell transplantation for myelodysplastic syndrome: current status. Arch. Immunol. Ther. Exp. (Warsz.) 2011, 60(1):31-41.
13. Delaney C., Ratajczak M.Z., Laughlin M.J. Strategies to enhance umbilical cord blood stem cell engraftment in adult patients. Expert Rev. Hematol. 2010, 3(3):273-283.
14. Dietz A.B., Bulur P.A., Emery R.L., Winters J.L., Epps D.E., Zubair A.C., Vuk-Pavlović S. A novel source of viable peripheral blood mononuclear cells from leukoreduction system chambers. Transfusion 2006, 46(12):2083-2089.
15. Douay L. From stem cell to red blood cells in vitro: "the 12 labors of Hercules". Clin. Lab. Med. 2010, 30(2):391-403.
16. Duchez P., Chevaleyre J., Vlaski M., Dazey B., Milpied N., Boiron J.M., Ivanovic Z. Definitive set-up of clinical-scale procedure for ex-vivo expansion of cord blood hematopoietic cells for transplantation. Cell Transplant. 2012, 21(11):2517-2521.
17. Gladstone D.E., Fuchs E. Hematopoietic stem cell transplantation for chronic lymphocytic leukemia. Curr. Opin. Oncol. 2012, 24(2):176-181.
18. Herbein G., Sovalat H., Wunder E., Baerenzung M., Bachorz J., Lewandowski H., Schweitzer C., Schmitt C., Kirn A., Hénon P. Isolation and identification of two CD34+ cell subpopulations from normal human peripheral blood. Stem Cells 1994, 12(2):187-197.
19. Hermitte F., Brunet de la Grange P., Belloc F., Praloran V., Ivanovic Z. Very low O2 concentration (0.1%) favors G0 return of dividing CD34+ cells. Stem Cells 2005, 24(1):65-73.
20. Hirayama F., Yamaguchi M., Yano M., Yasui K., Horie Y., Matsumoto K., Nagao N., Ikebuchi K., Azuma H., Ikeda H., Tani Y. Spontaneous and rapid reexpression of functional CXCR4 by human steady-state peripheral blood CD34+ cells. Int. J. Hematol. 2003, 78(1):48-55.
21. Holyoake T.L., Nicolini F.E., Eaves C.J. Functional differences between transplantable human hematopoietic stem cells from fetal liver, cord blood, and adult marrow. Exp. Hematol. 1999, 27(9):1418-1427.
22. Ivanovic Z., Duchez P., Morgan D.A., Hermitte F., Lafarge X., Chevaleyre J., Praloran V., Dazey B., Vezon G., Boiron J.M. Whole-blood leuko-depletion filters as a source of CD 34+ progenitors potentially usable in cell therapy. Transfusion 2006, 46(1):118-125.
23. Ivanovic Z., Duchez P., Chevaleyre J., Vlaski M., Lafarge X., Dazey B., Robert-Richard E., Mazurier F., Boiron J.M. Clinical-scale cultures of cord blood CD34(+) cells to amplify committed progenitors and maintain stem cell activity. Cell Transplant. 2011, 20(9):1453-1463.
24. Kessinger A., Armitage J.O., Landmark J.D., Weisenburger D.D. Reconstitution of human hematopoietic function with autologous cryopreserved circulating stem cells. Exp. Hematol. 1986, 14(3):192-196.
25. Körbling M., Freireich E.J. Twenty-five years of peripheral blood stem cell transplantation. Blood 2011, 117(24):6411-6416.
26. Körbling M., Dörken B., Ho A.D., Pezzutto A., Hunstein W., Fliedner T.M. Autologous transplantation of blood-derived hemopoietic stem cells after myeloablative therapy in a patient with Burkitt's lymphoma. Blood 1986, 67(2):529-532.
27. Lerner C., Harrison D.E. 5-Fluorouracil spares hemopoietic stem cells responsible for long-term repopulation. Exp. Hematol. 1990, 18(2):114-118.
28. Losordo D.W., Schatz R.A., White C.J., Udelson J.E., Veereshwarayya V., Durgin M., Poh K.K., Weinstein R., Kearney M., Chaudhry M., Burg A., Eaton L., Heyd L., Thorne T., Shturman L., Hoffmeister P., Story K., Zak V., Dowling D., Traverse J.H., Olson R.E., Flanagan J., Sodano D., Murayama T., Kawamoto A., Kusano K.F., Wollins J., Welt F., Shah P., Soukas P., Asahara T., Henry T.D. Intramyocardial transplantation of autologous CD34+ stem cells for intractable angina: a phase I/IIa double-blind, randomized controlled trial. Circulation 2007, 115(25):3165-3172.
29. Losordo D.W., Henry T.D., Davidson C., Sup Lee J., Costa M.A., Bass T., Mendelsohn F., Fortuin F.D., Pepine C.J., Traverse J.H., Amrani D., Ewenstein B.M., Riedel N., Story K., Barker K., Povsic T.J., Harrington R.A., Schatz R.A., ACT34-CMI Investigators Intramyocardial, autologous CD34+ cell therapy for refractory angina. Circ. Res. 2011, 109(4):428-436.
30. Mathe G., Bernard J., Schwarzenberg L., Larrieu M.J., Lalanne C.M., Dutreix A., Denoix P.F., Surmont J., Schwarzmann V., Ceoara B. Trial treatment of patients afflicted with acute leukemia in remission with total irradiation followed by homologous bone marrow transfusion. Rev. Fr. Etud. Clin. Biol. 1959, 4:675-704.
31. McCredie K.B., Hersh E.M., Freireich E.J. Cells capable of colony formation in the peripheral blood of man. Science 1971, 171(3968):293-294.
32. Meyer T.P., Zehnter I., Hofmann B., Zaisserer J., Burkhart J., Rapp S., Weinauer F., Schmitz J., Illert W.E. Filter Buffy Coats (FBC): a source of peripheral blood leukocytes recovered from leukocyte depletion filters. J. Immunol. Methods 2005, 307(1-2):150-166.
33. Néron S., Dussault N., Racine C. Whole-blood leukoreduction filters are a source for cryopreserved cells for phenotypic and functional investigations on peripheral blood lymphocytes. Transfusion 2006, 46(4):537-544.
34. Oran B., Shpall E. Umbilical cord blood transplantation: a maturing technology. Hematology Am. Soc. Hematol. Educ. Program 2012, 2012:215-222.
35. Pamphilon D., Siddiq S., Brunskill S., Dorée C., Hyde C., Horowitz M., Stanworth S. Stem cell donation-what advice can be given to the donor?. Br. J. Haematol. 2009, 147(1):71-76.
36. Peytour Y., Guitart A., Villacreces A., Chevaleyre J., Lacombe F., Ivanovic Z., Praloran V. Obtaining of CD34+ cells from healthy blood donors: development of a rapid and efficient procedure using leukoreduction filters. Transfusion 2010, 50(10):2152-2157.
37. Reiffers J., Bernard P., David B., Vezon G., Sarrat A., Marit G., Moulinier J., Broustet A. Successful autologous transplantation with peripheral blood hemopoietic cells in a patient with acute leukemia. Exp. Hematol. 1986, 14(4):312-315.
38. Richman C.M., Weiner R.S., Yankee R.A. Increase in circulating stem cells following chemotherapy in man. Blood 1976, 47(6):1031-1039.
39. Rosler E.S., Brandt J.E., Chute J., Hoffman R. An in vivo competitive repopulation assay for various sources of human hematopoietic stem cells. Blood 2000, 96(10):3414-3421.
40. Sánchez A., Schimmang T., García-Sancho J. Cell and tissue therapy in regenerative medicine. Adv. Exp. Med. Biol. 2012, 741:89-102.
41. Sato N., Sawada K., Takahashi T.A., Mogi Y., Asano S., Koike T., Sekiguchi S. A time course study for optimal harvest of peripheral blood progenitor cells by granulocyte colony-stimulating factor in healthy volunteers. Exp. Hematol. 1994, 22(10):973-978.
42. Siena S., Bregni M., Brando B., Ravagnani F., Bonadonna G., Gianni A.M. Circulation of CD34+ hematopoietic stem cells in the peripheral blood of high-dose cyclophosphamide-treated patients: enhancement by intravenous recombinant human granulocyte-macrophage colony-stimulating factor. Blood 1989, 74(6):1905-1914.
43. Siena S., Bregni M., Brando B., Belli N., Ravagnani F., Gandola L., Stern A.C., Lansdorp P.M., Bonadonna G., Gianni A.M. Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients. Blood 1991, 77(2):400-409.
44. Storb R., Graham T.C., Epstein R.B., Sale G.E., Thomas E.D. Demonstration of hemopoietic stem cells in the peripheral blood of baboons by cross circulation. Blood 1977, 50(3):537-542.
45. Thomas E.D. Bone marrow transplantation: a review. Semin. Hematol. 1999, 36(4 Suppl. 7):95-103.
46. To L.B., Haylock D.N., Kimber R.J., Juttner C.A. High levels of circulating haemopoietic stem cells in very early remission from acute non-lymphoblastic leukaemia and their collection and cryopreservation. Br. J. Haematol. 1984, 58(3):399-410.
47. To L.B., Levesque J.P., Herbert K.E. How I treat patients who mobilize hematopoietic stem cells poorly. Blood 2011, 118(17):4530-4540.
48. Vlaski M., Lafarge X., Chevaleyre J., Duchez P., Boiron J.M., Ivanovic Z. Low oxygen concentration as a general physiologic regulator of erythropoiesis beyond the EPO-related downstream tuning and a tool for the optimization of red blood cell production ex vivo. Exp. Hematol. 2009, 37(5):573-584.
49. Wang J.C., Doedens M., Dick J.E. Primitive human hematopoietic cells are enriched in cord blood compared with adult bone marrow or mobilized peripheral blood as measured by the quantitative in vivo SCID-repopulating cell assay. Blood 1997, 89(11):3919-3924.
50. Zuba-Surma E.K., Wojakowski W., Madeja Z., Ratajczak M.Z. Stem cells as a novel tool for drug screening and treatment of degenerative diseases. Curr. Pharm. Des. 2012, 18(18):2644-2656.